These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 6423612)
41. Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancer. Glenny AM; Fernandez Mauleffinch LM; Pavitt S; Walsh T Cochrane Database Syst Rev; 2009 Jan; (1):CD006706. PubMed ID: 19160295 [TBL] [Abstract][Full Text] [Related]
42. Skin infections. Brigden D Br Med Bull; 1985 Oct; 41(4):357-60. PubMed ID: 2413950 [No Abstract] [Full Text] [Related]
43. [Viral diseases of the mouth mucosa treated with Morgalin]. Sallay K; Gürtler A Orv Hetil; 1969 Nov; 110(48):2813-4. PubMed ID: 5362772 [No Abstract] [Full Text] [Related]
44. Acyclovir: is it an effective virostatic agent for orofacial infections? Lavelle CL J Oral Pathol Med; 1993 Oct; 22(9):391-401. PubMed ID: 8301603 [TBL] [Abstract][Full Text] [Related]
45. Valacyclovir for the treatment of genital herpes. Brantley JS; Hicks L; Sra K; Tyring SK Expert Rev Anti Infect Ther; 2006 Jun; 4(3):367-76. PubMed ID: 16771614 [TBL] [Abstract][Full Text] [Related]
47. Research in simple blind with natural interferon alpha at low dosage on subjects affected by labialis and genitalis herpes simplex. Scalvenzi M; Ceddia C Clin Ter; 2000; 151(1 Suppl 1):13-8. PubMed ID: 10876961 [TBL] [Abstract][Full Text] [Related]
48. Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy. Richards DM; Carmine AA; Brogden RN; Heel RC; Speight TM; Avery GS Drugs; 1983 Nov; 26(5):378-438. PubMed ID: 6315332 [TBL] [Abstract][Full Text] [Related]
49. Oral and perioral herpes simplex virus type 1 (HSV-1) infection: review of its management. Arduino PG; Porter SR Oral Dis; 2006 May; 12(3):254-70. PubMed ID: 16700734 [TBL] [Abstract][Full Text] [Related]
50. Topical treatment of recurrent herpes simplex and post-herpetic erythema multiforme with low concentrations of zinc sulphate solution. Brody I Br J Dermatol; 1981 Feb; 104(2):191-4. PubMed ID: 7213551 [TBL] [Abstract][Full Text] [Related]
52. [Herpes simplex virus infections]. Kunkel M; Gärtner L; Oberender H Z Gesamte Inn Med; 1985 Apr; 40(7):189-93. PubMed ID: 4039869 [TBL] [Abstract][Full Text] [Related]
53. Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections. Perry CM; Faulds D Drugs; 1996 Nov; 52(5):754-72. PubMed ID: 9118821 [TBL] [Abstract][Full Text] [Related]
54. Acyclovir and other chemotherapy for herpes group viral infections. Balfour HH Annu Rev Med; 1984; 35():279-91. PubMed ID: 6326661 [TBL] [Abstract][Full Text] [Related]
55. [Therapy of recurrent herpes infections with oral acyclovir]. Nolting S Fortschr Med; 1985 Feb; 103(6):130-2. PubMed ID: 3988215 [No Abstract] [Full Text] [Related]
56. Multicenter randomized study of inosine pranobex versus acyclovir in the treatment of recurrent herpes labialis and recurrent herpes genitalis in Chinese patients. You Y; Wang L; Li Y; Wang Q; Cao S; Tu Y; Li S; Bai L; Lu J; Wei Z; Chen W; Hao F J Dermatol; 2015 Jun; 42(6):596-601. PubMed ID: 25819042 [TBL] [Abstract][Full Text] [Related]